The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 05, 2019

Filed:

Sep. 18, 2015
Applicant:

The Johns Hopkins University, Baltimore, MD (US);

Inventors:

Paul F. Worley, Baltimore, MD (US);

DeSheng Xu, Lutherville-Timonium, MD (US);

Meifang Xiao, Baltimore, MD (US);

Assignee:

The Johns Hopkins University, Baltimore, MD (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); A61K 51/10 (2006.01); C07K 16/18 (2006.01); C07K 16/38 (2006.01); G01N 33/58 (2006.01); C12N 5/079 (2010.01); G01N 33/68 (2006.01); G01N 33/566 (2006.01); G01N 33/53 (2006.01); G06F 19/00 (2018.01);
U.S. Cl.
CPC ...
G01N 33/6896 (2013.01); C07K 16/18 (2013.01); G01N 33/53 (2013.01); G01N 33/566 (2013.01); G01N 33/6851 (2013.01); G01N 2800/2821 (2013.01); G01N 2800/2835 (2013.01); G06F 19/00 (2013.01);
Abstract

The present invention relates to the field of cognitive function. More specifically, the present invention provides compositions and methods useful for assessing cognitive dysfunction/function in Alzheimer's disease and other diseases of cognition. In one embodiment, the method comprises the steps of (a) reducing heterocomplexes comprising NPTX1 and NPTX2 present in a biological sample obtained from the patient into NPTX1 and NPTX2 monomers; (b) covalently modifying the thiol groups of the NPTX1 and NPTX2 monomers to prevent re-formation of NPTX1/NPTX2 heterocomplexes; (c) detecting NPTX2 in the sample; and (d) assessing cognitive function in the patient by comparing NPTX2 detected in the sample to a control.


Find Patent Forward Citations

Worley, Paul. (2019). Biomarkers of congnitive dysfunction (U.S. Patent No. 10222386). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10222386

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…